Our results show a correlation between EMX2 levels and 5-FU sensitivity (inversely correlated with IC50 values to 5-FU), suggesting that decreased expression of EMX2 may contribute to chemoresistance in ESCC. Here, EMX2 is linked to esophageal squamous cell carcinoma.